Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
JAK genes and cancer

JAK genes and cancer

Benefits and risks of breastfeeding

Benefits and risks of breastfeeding

IMPACT: Increasing clinical trial participation

IMPACT: Increasing clinical trial participation

Unique role for blood formation gene MLL identified

Unique role for blood formation gene MLL identified

Ultraconserved non-coding RNAs may be important in human cancer

Ultraconserved non-coding RNAs may be important in human cancer

Congestive heart failure is rare among leukemia patients who take imatinib

Congestive heart failure is rare among leukemia patients who take imatinib

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Genetics of imatinib resistance in acute lymphoblastic leukemia

Genetics of imatinib resistance in acute lymphoblastic leukemia

Biologic treatment for rheumatoid arthritis and the risk of cancer

Biologic treatment for rheumatoid arthritis and the risk of cancer

Fingolimod shows promise in 2 lethal leukemias

Fingolimod shows promise in 2 lethal leukemias

FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

St. Jude discovers factors that accelerate resistance to Gleevec targeted therapy in lymphoblastic leukemia

St. Jude discovers factors that accelerate resistance to Gleevec targeted therapy in lymphoblastic leukemia

Potential new leukemia drug

Potential new leukemia drug

Nuclear nanocapsules to target tiny tumors

Nuclear nanocapsules to target tiny tumors

First large-scale study of proteins inside human cells called Jurkat T cells

First large-scale study of proteins inside human cells called Jurkat T cells

Rapamycin study is first stage in development of new treatment

Rapamycin study is first stage in development of new treatment

Study helps predict anesthesia-linked risks for children with chest tumors

Study helps predict anesthesia-linked risks for children with chest tumors

Cancer stem cell scientists get $1.7 million to develop new leukemia drugs

Cancer stem cell scientists get $1.7 million to develop new leukemia drugs

Critical blood shortage in southeastern Michigan

Critical blood shortage in southeastern Michigan

New formula to gauge risk of disease clusters

New formula to gauge risk of disease clusters